ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Liver transplantation"

  • 2021 American Transplant Congress

    Role of Ferroptosis Inhibitors in Mitigating Ischemia-Reperfusion Injury in Marginal Livers Using a Novel Protect Model

    M. D. Nazzal, J. Van Nispen, A. Armstrong, V. Murali, E. Song, M. Voigt, A. Samaddar, E. Madsen, C. Manithody, J. Krebs, D. Blackall, D. Carpenter, C. Varma, J. Teckman, A. Jain

    Saint Louis University, Saint Louis, MO

    *Purpose: The discard rate of deceased donor livers (DDL) remains high at nearly 9% and incudes livers that are steatotic, old in age, and from…
  • 2021 American Transplant Congress

    Long Term Survival After Liver Transplantation for Advanced, Unresectable Intrahepatic Cholangiocarcinoma

    R. R. McMillan1, S. Kodali1, M. Javle2, A. Saharia1, C. M. Mobley1, M. J. Hobeika1, A. Shetty1, D. W. Victor1, R. McFadden1, M. Abdelrahim1, K. Heyne1, A. O. Gaber1, R. M. Ghobrial1

    1Houston Methodist Hospital, Houston, TX, 2MD Anderson Cancer Center, Houston, TX

    *Purpose: Intrahepatic cholangiocarcinoma (ICCA) has traditionally been considered a contraindication to liver transplantation (LT). We previously reported a case series of six patients with large,…
  • 2021 American Transplant Congress

    Hla-dq Epitope Mismatch Predicts De Novo Donor-Specific Antibody Formation and Acute Cellular Rejection After Living Donor Liver Transplantation

    K. Ono, K. Ide, Y. Tanaka, M. Ohira, H. Tahara, N. Tanimine, S. Akimoto, Y. Imaoka, K. Sato, H. Yamane, N. Tsukiyama, R. Ide, T. Mochizuki, H. Ohdan

    Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health S, Hiroshima University, Hiroshima City, Japan

    *Purpose: Epitope mismatch (MM) effect on living donor liver transplantation (LDLT) has not been studied in detail. This study aimed to investigate the role of…
  • 2021 American Transplant Congress

    Subjective Cognition Among Liver Transplant Recipients

    D. Ko1, M. S. Dietrich2, K. A. Gifford3, S. H. Ridner2

    1School of Nursing, Northeastern University, Boston, MA, 2School of Nursing, Vanderbilt University, Nashville, TN, 3Department of Neurology, Vanderbilt University Medical Center, Nashville, TN

    *Purpose: Regular assessment of cognition is highly suggested to facilitate the early detection and treatment of cognitive impairment in the liver transplant (LT) population. While…
  • 2021 American Transplant Congress

    Early Portal Vein Ligation in the Setting of Shorter Hepatectomy May Contribute to Better Surgical Outcomes in Deceased Donor Liver Transplantation

    K. Delvecchio, T. Kitajima, A. Mohamed, S. Yeddula, M. Tayseer, T. Ivanics, K. Collins, M. Rizzari, A. Yoshida, M. Abouljoud, S. Nagai

    Henry Ford Hosptial, Detroit, MI

    *Purpose: Few published reports have suggested lower blood loss in association with early portal vein ligation (e-PVL) during liver transplantation surgery, however there are currently…
  • 2021 American Transplant Congress

    Outcomes of Surgical Resection versus Liver Transplantation in Hilar Cholangiocarcinoma

    M. K. White1, F. Aucejo2, A. Moro2, K. Sasaki2, K. Stephans3, B. Estfan4, C. Quintini2, B. Eghtesad2, K. Hashimoto2, F. Masato2, C. Miller2, K. Menon5

    1Cleveland Clinic, Cleveland, OH, 2General Surgery, Cleveland Clinic, Cleveland, OH, 3Radiation Oncology, Cleveland Clinic, Cleveland, OH, 4Oncology, Cleveland Clinic, Cleveland, OH, 5Gastroenterology & Hepatology, Cleveland Clinic, Cleveland, OH

    *Purpose: To compare the outcomes of patients with hilar cholangiocarcinoma (hCCA) who underwent either surgical resection or liver transplantion (LT).*Methods: All hCCA patients who underwent…
  • 2021 American Transplant Congress

    Role of Recovering Surgeon in DCD Liver Transplant Outcomes

    E. Macdonough, K. Pont, B. Aqel, K. Valenti, W. Hewitt, A. Moss, K. S. Reddy, C. Jadlowiec

    Mayo Clinic, Phoenix, AZ

    *Purpose: Donation after cardiac death (DCD) liver transplant (LT) outcomes have continued to improve. Variability in outcomes has been attributed to center and recovering surgeon…
  • 2021 American Transplant Congress

    Temporal Changes in Renal Function Predict Waitlist Death or Deterioration in Pediatric Liver Transplantation

    N. Thalji, L. Thalji, S. Ibrahim, T. Diwan, P. Kamath, J. Heimbach

    Mayo Clinic Rochester, Minnesota, Rochester, MN

    *Purpose: Renal dysfunction at the time of listing predicts inferior waitlist outcomes in pediatric liver transplant candidates, independent of the Pediatric End-Stage Liver Disease (PELD)…
  • 2021 American Transplant Congress

    Machine Perfusion of Kidney Grafts in Simultaneous Liver Kidney Transplantation: National Trends and Outcomes

    A. Chang1, M. Chen1, P. Abt1, T. Bittermann2

    1Surgery, University of Pennsylvania, Philadelphia, PA, 2Gastroenterology, University of Pennsylvania, Philadelphia, PA

    *Purpose: In this study we analyze the SRTR liver data set to determine the trends in machine perfusion of kidney grafts prior to SLK and…
  • 2021 American Transplant Congress

    Impact of a Cmv Cell Mediated Immunity Based Protocol on Guiding Cmv Prophylaxis Following Pediatric Liver Transplantation – A Single Center Experience

    G. Kalkan1, S. Ball2, L. McConnell2, D. M. Desai3, A. Aqul3, P. K. Sue1

    1Infectious Disease, University of Texas Southwestern Medical Center, Dallas, TX, 2Solid Organ Transplant Program, Children's Health, Dallas, TX, 3Solid Organ Transplant Program, University of Texas Southwestern Medical Center, Dallas, TX

    *Purpose: Cytomegalovirus (CMV) is an important cause of morbidity following pediatric orthotopic liver transplantation (OLT), especially among high risk (HR) CMV D+/R- recipients. In 2019,…
  • « Previous Page
  • 1
  • …
  • 29
  • 30
  • 31
  • 32
  • 33
  • …
  • 180
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences